A.S.P.E.N. Wins 2012 Profiles of Excellence Award for PN Safety and Drug Shortages Advocacy

FOR IMMEDIATE RELEASE

Prestigious medical award recognizes A.S.P.E.N. for its dedication to parenteral nutrition advocacy 

July 31, 2012, Silver Spring, MD –The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)—a leader in clinical nutrition and metabolism education and advocacy—was selected as one of the 2012 Profiles of Excellence (PoE) Award winners for its outstanding advocacy achievements in parenteral nutrition (PN) (intravenous
nutrition) safety and drug shortages. 
 
The second annual PoE Awards were presented at the 2012 American Association of Medical Society Executives (AAMSE) Annual Conference in Los Angeles on July 17. The awards recognize programs and campaigns that have made positive impacts on medical societies’ members and communities. Out of 26 nominations, a panel of AAMSE
member judges selected A.S.P.E.N. as the winner in the advocacy category. 
 
“We are thrilled to accept this high honor for our PN advocacy efforts,” said Debra S. BenAvram, CAE, Chief Executive Officer, A.S.P.E.N. “We have an incredible group of volunteers who contribute their knowledge and energy to our Society every year. We would not have won this award without the tireless efforts and dedication of our Clinical Practice and Public Policy Committee volunteers and without the commitment from our
Board of Directors.” 
 
During the past year, many circumstances and incidents have threatened the safety of PN as an important therapy—particularly the ongoing shortage of key IV ingredients, or components. A.S.P.E.N. is committed to addressing the safety of PN prescribing, compounding, and delivery, and is addressing the ongoing shortage of vitamins,
electrolytes and other IV nutrition ingredients that has critically impacted hospitals and some infusion companies nationwide. 
 
There are multiple PN components on the American Society of Health System Pharmacists (ASHP) drug shortages list. A recent study by the American Hospital association found that 89% of hospitals have experienced nutrition product shortages. The FDA reports that in 2010, 74% of all product shortages were IV medications,
including those needed for PN. And, all PN products except dextrose and water have seen in short supply since the spring of 2010. 
 
The drug shortage crisis continues in the U.S. and threatens the integrity of the pharmaceutical supply chain and compromises patient care, especially for those requiring PN therapy. Providing PN therapy during product shortages requires vigilance  and continuous assessment of the entire PN process to optimize patient care quality and 
avoid patient harm. A.S.P.E.N. is committed to this crucial issue and continues to provide the latest updates and education to the clinicians caring for patients on PN. 
 
Learn more about A.S.P.E.N.’s PoE award winning entry or about the Society’s drug shortages efforts today. 
 
****** 
The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is dedicated to improving patient 
care by advancing the science and practice of nutrition support therapy and metabolism. Founded in 1976, 
A.S.P.E.N. is an interdisciplinary organization whose members are involved in the provision of clinical 
nutrition therapies, including parenteral and enteral nutrition. With more than 5,500 members from around 
the world, A.S.P.E.N. is a community of dietitians, nurses, pharmacists, physicians, scientists, students and 
other health professionals from every facet of nutrition support clinical practice, research and education. 
 # # #